Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 15;14(7):995-1012.
doi: 10.4239/wjd.v14.i7.995.

Advanced glycation end product signaling and metabolic complications: Dietary approach

Affiliations
Review

Advanced glycation end product signaling and metabolic complications: Dietary approach

Mohammad Idreesh Khan et al. World J Diabetes. .

Abstract

Advanced glycation end products (AGEs) are a heterogeneous collection of compounds formed during industrial processing and home cooking through a sequence of nonenzymatic glycation reactions. The modern western diet is full of heat-treated foods that contribute to AGE intake. Foods high in AGEs in the contemporary diet include processed cereal products. Due to industrialization and marketing strategies, restaurant meals are modified rather than being traditionally or conventionally cooked. Fried, grilled, baked, and boiled foods have the greatest AGE levels. Higher AGE-content foods include dry nuts, roasted walnuts, sunflower seeds, fried chicken, bacon, and beef. Animal proteins and processed plant foods contain furosine, acrylamide, heterocyclic amines, and 5-hydroxymethylfurfural. Furosine (2-furoil-methyl-lysine) is an amino acid found in cooked meat products and other processed foods. High concentrations of carboxymethyl-lysine, carboxyethyl-lysine, and methylglyoxal-O are found in heat-treated nonvegetarian foods, peanut butter, and cereal items. Increased plasma levels of AGEs, which are harmful chemicals that lead to age-related diseases and physiological aging, diabetes, and autoimmune/inflammatory rheumatic diseases such as systemic lupus erythematosus and rheumatoid arthritis. AGEs in the pathophysiology of metabolic diseases have been linked to individuals with diabetes mellitus who have peripheral nerves with high amounts of AGEs and diabetes has been linked to increased myelin glycation. Insulin resistance and hyperglycemia can impact numerous human tissues and organs, leading to long-term difficulties in a number of systems and organs, including the cardiovascular system. Plasma AGE levels are linked to all-cause mortality in individuals with diabetes who have fatal or nonfatal coronary artery disease, such as ventricular dysfunction. High levels of tissue AGEs are independently associated with cardiac systolic dysfunction in diabetic patients with heart failure compared with diabetic patients without heart failure. It is widely recognized that AGEs and oxidative stress play a key role in the cardiovascular complications of diabetes because they both influence and are impacted by oxidative stress. All chronic illnesses involve protein, lipid, or nucleic acid modifications including crosslinked and nondegradable aggregates known as AGEs. Endogenous AGE formation or dietary AGE uptake can result in additional protein modifications and stimulation of several inflammatory signaling pathways. Many of these systems, however, require additional explanation because they are not entirely obvious. This review summarizes the current evidence regarding dietary sources of AGEs and metabolism-related complications associated with AGEs.

Keywords: Advanced glycation end products; Cardiac complication; Diabetes; Food safety; Heat-treated diets; Maillard reaction products; Metabolic disorder; Receptor for advanced glycation end products.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Factors involved in accelerating advanced glycation end product formation and accumulation in the body. CEA: N7–(1-carboxyethyl)arginine; CEC: Carboxyethyl cysteine; CEL: N’-(1-carboxyethyl)lysine; CML: Carboxymethyl-lysine; MODIC: 2-ammonio-6-({2-[4-ammonio-5-oxido-5-oxopently)amino]4-methyl-4,5-dihydro-1H imidazol-5 ylidene}amino)hexanoate; MOLD: Methylglyoxal-lysine dimer; DODIC: N6-{2-{[(4S)-4-ammonio-5-oxido-5-oxopentyl]amino}-5-[(2S,3R)-2,3,4-trihydroxybutyl]- 3,5-dihydro-4H-imidazol-4-ylidene}-L-lysinate; DOLD: 1,3-, di(N’-lysino)-4-(2,3,4-trihydroxybutyl)-imidazolium.
Figure 2
Figure 2
Sources of dietary advanced glycation end products. CEL: Carboxyethyl-lysine; CML: Carboxymethyl-lysine; GO: Glyoxal; HMF: Hydroxymethylfurfural; MGO: Methylglyoxal.
Figure 3
Figure 3
Advanced glycation end products, advanced glycation end products receptor mediated pathways, production of cytokines, oxidative stress and organ involvement. AGEs: Advanced glycation end products; ERK: Extracellular signal regulated kinase; ISRE: Interferon-sensitive response element; JAK: Janus kinase; PI3K: Phosphoinositide 3-kinase; mTOR: Mammalian target of rapamycin; RAGE: Advanced glycation end products receptor; ROS: Reactive oxygen species.

Similar articles

Cited by

References

    1. Kim CS, Park S, Kim J. The role of glycation in the pathogenesis of aging and its prevention through herbal products and physical exercise. J Exerc Nutrition Biochem. 2017;21:55–61. - PMC - PubMed
    1. Monnier VM, Taniguchi N. Advanced glycation in diabetes, aging and age-related diseases: editorial and dedication. Glycoconj J. 2016;33:483–486. - PubMed
    1. Vlassara H, Striker GE. Advanced glycation endproducts in diabetes and diabetic complications. Endocrinol Metab Clin North Am. 2013;42:697–719. - PubMed
    1. Nowak A, Przywara-Chowaniec B, TYRPIEń-Golder K, Nowalany-Kozielska E. Systemic lupus erythematosus and glycation process. Cent Eur J Immunol. 2020;45:93–98. - PMC - PubMed
    1. Johnson EM, Christian MS, Dansky L, Gabel BE. Use of the adult developmental relationship in prescreening for developmental hazards. Teratog Carcinog Mutagen. 1987;7:273–285. - PubMed
-